- Home
- OCUL vs IMKTA Comparison
OCUL vs IMKTA Comparison
Compare OCUL & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUL
- IMKTA
- Stock Information
- Founded
- OCUL 2006
- IMKTA 1963
- Country
- OCUL United States
- IMKTA United States
- Employees
- OCUL N/A
- IMKTA 26360
- Industry
- OCUL Biotechnology: Pharmaceutical Preparations
- IMKTA Food Chains
- Sector
- OCUL Health Care
- IMKTA Consumer Staples
- Exchange
- OCUL Nasdaq
- IMKTA Nasdaq
- Market Cap
- OCUL 1.4B
- IMKTA 1.2B
- IPO Year
- OCUL 2014
- IMKTA N/A
- Fundamental
- Price
- OCUL $8.01
- IMKTA $63.07
- Analyst Decision
- OCUL Strong Buy
- IMKTA
- Analyst Count
- OCUL 8
- IMKTA 0
- Target Price
- OCUL $16.50
- IMKTA N/A
- AVG Volume (30 Days)
- OCUL 874.8K
- IMKTA 139.0K
- Earning Date
- OCUL 03-10-2025
- IMKTA 02-06-2025
- Dividend Yield
- OCUL N/A
- IMKTA 1.05%
- EPS Growth
- OCUL N/A
- IMKTA N/A
- EPS
- OCUL N/A
- IMKTA 5.56
- Revenue
- OCUL $61,442,000.00
- IMKTA $5,639,609,434.00
- Revenue This Year
- OCUL $11.40
- IMKTA N/A
- Revenue Next Year
- OCUL $13.58
- IMKTA N/A
- P/E Ratio
- OCUL N/A
- IMKTA $11.35
- Revenue Growth
- OCUL 6.45
- IMKTA N/A
- 52 Week Low
- OCUL $3.76
- IMKTA $59.73
- 52 Week High
- OCUL $11.78
- IMKTA $85.87
- Technical
- Relative Strength Index (RSI)
- OCUL 38.27
- IMKTA 38.17
- Support Level
- OCUL $7.99
- IMKTA $62.07
- Resistance Level
- OCUL $8.43
- IMKTA $64.72
- Average True Range (ATR)
- OCUL 0.38
- IMKTA 1.57
- MACD
- OCUL -0.03
- IMKTA 0.09
- Stochastic Oscillator
- OCUL 20.66
- IMKTA 22.47
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
About IMKTA Ingles Markets Incorporated
Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.